De Novo
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old (NCT04687761) | PETHEMA Foundation | 2020-11-04 |
| BIOFLOW-SV All Comers Registry (NCT03600948) | Biotronik AG | 2018-08-27 |
| MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate (NCT02067143) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2014-05-20 |
Track De Novo automatically
Every clearance here is in the API, with alerts when new ones post.